低分子創薬の世界市場レポート 2025年

低分子創薬の市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）11.7%で1,069億1,000万米ドルに成長します。予測期間の成長は、新規治療標的の出現、患者中心の創薬、薬剤とデバイスの組み合わせ製品、リアルワールドエビデンスの活用、ファーマコゲノミクスの統合、グローバルヘルスの課題などに起因すると考えられます。予測期間の主な動向としては、フラグメントベースの創薬、創薬における人工知能の統合、RNA標的治療薬、共同研究・提携、ドラッグデリバリーの革新、オルガノイドや3D細胞培養モデルの採用などが挙げられます。

慢性疾患の増加が予想され、低分子創薬市場の成長を促進します。慢性疾患は、1年以上持続し、継続的な医療を必要とすることが特徴で、HIV、がん、感染症、心臓病、腎臓病などの疾患が含まれます。低分子医薬品はこれらの慢性疾患の治療に有効であり、一般的に患者にとって費用対効果が高いことが証明されています。米国国立衛生研究所（NIH）の2023年の報告によると、米国では、少なくとも1つの慢性疾患を持つ50歳以上の人口が99.5％増加し、2020年の7,152万2,000人から2050年には1億4,266万人になると予想されています。さらに、多疾患併存者数は91.16％増加し、2020年の783万400人から2050年には1,496万8,000人に達すると予測されます。このように、慢性疾患の罹患率の増加が低分子創薬市場拡大の原動力となっています。

ヘルスケアにおける研究開発の促進を目的とした政府のイニシアチブは、低分子創薬市場の成長を促進すると予測されています。こうした取り組みには、ヘルスケアの課題に対処し、社会の前向きな変化を促進するために、政府当局がさまざまなレベルで実施する具体的な行動、プログラム、政策が含まれます。2022年、英国政府はヘルスケア社会介護省（Department of Health and Social Care）から報告されたように、ヘルスケア研究と製造の強化のために2億6,000万ポンド（米国2億7,065万米ドル）の資金提供を約束しました。BEISとDHSCが提供するこの資金は、革新的なプライバシー保護プラットフォームと臨床研究サービスを通じて、診断と治療におけるNHS主導の健康調査を支援します。さらに6,000万英ポンド（6,360万米ドル）が、英国におけるライフサイエンス製造業の拡大を支援するために割り当てられました。このように、ヘルスケアにおける研究開発に焦点を当てた政府のイニシアチブは、低分子創薬市場の推進に極めて重要な役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の低分子創薬市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の低分子創薬市場：成長率分析
• 世界の低分子創薬市場の実績：規模と成長、2019～2024年
• 世界の低分子創薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の低分子創薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の低分子創薬市場：薬の種類別、実績と予測、2019～2024年、2024～2029年、2034年
• 低分子医薬品
• 生物学的医薬品
• 世界の低分子創薬市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ハイスループットスクリーニング
• ファーマコゲノミクス
• コンビナトリアルケミストリー
• ナノテクノロジー
• その他
• 世界の低分子創薬市場：治療領域別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍
• 中枢神経系
• 心臓血管
• 呼吸器
• 代謝障害
• 胃腸
• その他
• 世界の低分子創薬市場：プロセス/フェーズ別、実績と予測、2019～2024年、2024～2029年、2034年
• ターゲットIDまたは検証
• ヒットの生成と選択
• リード識別
• リード最適化
• 世界の低分子創薬市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬会社
• 契約研究機関
• その他
• 世界の低分子創薬市場：低分子医薬品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ジェネリック低分子医薬品
• 新規低分子医薬品
• 世界の低分子創薬市場：生物学的医薬品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• モノクローナル抗体
• ワクチン
• 組み換えタンパク質
• 細胞および遺伝子治療

第7章 地域別・国別分析

• 世界の低分子創薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の低分子創薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 低分子創薬市場：競合情勢
• 低分子創薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Johnson & Johnson
• Gilead Sciences Inc.
• Merck KGaA
• Novartis AG
• 4SC AG
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Labcorp Drug Development
• ICON Public Limited Company
• Charles River Laboratories
• Aluda Pharmaceuticals
• Clinuvel Pharmaceuticals
• Corcept Therapeutics
• Edison Oncology
• Escend Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 低分子創薬市場2029年：新たな機会を提供する国
• 低分子創薬市場2029年：新たな機会を提供するセグメント
• 低分子創薬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Small molecule drug discovery involves the identification of medicines characterized by their low molecular weight, allowing them to easily penetrate cells and either cure or prevent diseases.

The primary categories within small molecule drug discovery are small molecule drugs and biologic drugs. Small molecule drugs are organic chemicals with relatively low molecular weights (less than 900 daltons) that affect biological processes. Various technologies employed in this field include high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others. These technologies find application in therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases, respiratory conditions, metabolic disorders, gastrointestinal ailments, among others. The drug discovery process involves phases such as target identification or validation, hit generation and selection, lead identification, and lead optimization, utilized by pharmaceutical companies, contract research organizations, and other entities in the industry.

The small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides small molecule drug discovery market statistics, including small molecule drug discovery industry global market size, regional shares, competitors with a small molecule drug discovery market share, detailed small molecule drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule drug discovery industry. This small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule drug discovery market size has grown strongly in recent years. It will grow from $62.44 billion in 2024 to $68.57 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to drug repurposing initiatives, automation in drug discovery, increased investment in r&d, regulatory support for drug development, advancements in high-throughput screening.

The small molecule drug discovery market size is expected to see rapid growth in the next few years. It will grow to $106.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to emergence of novel therapeutic targets, patient-centric drug discovery, drug-device combination products, real-world evidence utilization, pharmacogenomics integration, global health challenges. Major trends in the forecast period include fragment-based drug discovery, integration of artificial intelligence in drug discovery, rna-targeted therapeutics, collaborations and partnerships, innovations in drug delivery, adoption of organoids and 3d cell culture models.

The anticipated rise in chronic diseases is set to propel the growth of the small molecule drug discovery market. Chronic diseases, characterized by lasting a year or longer and requiring continuous medical care, include conditions such as HIV, cancer, infections, heart disease, and renal disease. Small-molecule medications prove to be effective in treating these chronic conditions and are generally more cost-effective for patients. According to a report from the National Institutes of Health (NIH) in 2023, the United States is expected to witness a 99.5% increase in the number of people aged 50 and older with at least one chronic illness, rising from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is projected to rise by 91.16%, reaching 14.968 million in 2050 from 7.8304 million in 2020. Consequently, the growing incidence of chronic diseases is a driving force behind the expansion of the small molecule drug discovery market.

Government initiatives aimed at promoting research and development in healthcare are anticipated to drive the growth of the small molecule drug discovery market. These initiatives involve specific actions, programs, or policies undertaken by government authorities at various levels to address healthcare challenges and foster positive changes in society. In 2022, the UK government, as reported by the Department of Health and Social Care, committed £260 million (US $270.65 million) in funding to enhance healthcare research and manufacturing. This funding, provided by BEIS and DHSC, supports NHS-led health research in diagnostics and treatment through innovative privacy-preserving platforms and clinical research services. An additional £60 million (US $63.60 million) was allocated to support the expansion of life sciences manufacturing in the UK. Consequently, government initiatives focused on research and development in healthcare play a pivotal role in propelling the small molecule drug discovery market.

Technological innovations emerge as a prominent trend in the small molecule drug discovery market, with major companies concentrating on the development of new products. For instance, in January 2023, Dotmatics, a US-based provider of a digital science platform, introduced the Small Molecule Drug Discovery Solution. Uniquely designed with an integrated scientific R&D platform featuring pre-configured workflows and expanded data management capabilities, this solution aims to reduce operational inefficiencies and expedite the process of transforming data into actionable insights. The focus on technological advancements underscores the commitment of industry leaders to drive advancements in the small molecule drug discovery field.

Prominent companies within the small molecule drug discovery sector are actively engaging in strategic partnerships as a key strategy to drive revenues. These collaborations often serve as catalysts for innovation by harnessing the combined expertise of different entities. In a noteworthy example, in November 2023, Evommune, a non-profit organization based in the United States, joined forces with Accutar Biotechnology, a US-based biotechnology company, in a strategic partnership focused on AI-based drug discovery, specifically targeting chronic inflammatory diseases. This collaborative effort aims to capitalize on Accutar's proprietary AI platform and Evommune's specialized expertise to identify novel small molecule drug candidates.

A significant partnership occurred in July 2022 when GSK Plc., a prominent pharmaceutical and biotechnology company based in the UK, acquired Sierra Oncology Inc. for a substantial deal valued at 1.9 billion dollars. This strategic acquisition plays a crucial role in expanding GSK's advanced cancer portfolio, underscoring its commitment to improving patient outcomes and maximizing shareholder value. Sierra Oncology, a US-based clinical-stage drug development company, specializes in advancing targeted therapeutics for the treatment of cancer patients. The collaboration is expected to enable GSK to establish a sustainable process for innovative therapeutics, utilizing modalities such as small molecules, antibodies, antibody-drug conjugates, and cell therapy. This strategic move reinforces GSK's position in the small molecule drug discovery landscape while broadening its capabilities in addressing critical healthcare challenges.

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule drug discovery market consists of sales of diphenhydramine, aspirin, and other "medicine cabinet" drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Small Molecule Drugs; Biologic Drugs
• 2) By Technology: High Throughput Screening; Pharmacogenomics; Combinatorial Chemistry; Nanotechnology; Others
• 3) By Therapeutic Area: Oncology; Central Nervous System; Cardiovascular; Respiratory; Metabolic Disorders; Gastrointestinal; Others
• 4) By Process Or Phase: Target ID Or Validation; Hit Generation And Selection; Lead Identification; Lead Optimization
• 5) By End-User: Pharmaceutical Companies; Contract Research Organizations; Others
• Subsegments:
• 1) By Small Molecule Drugs: Generic Small Molecule Drugs; Novel Small Molecule Drugs
• 2) By Biologic Drugs: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell And Gene Therapies
• Companies Mentioned: Pfizer Inc.; GlaxoSmithKline plc; AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Drug Discovery Market Characteristics

3. Small Molecule Drug Discovery Market Trends And Strategies

4. Small Molecule Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Small Molecule Drug Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Molecule Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Molecule Drug Discovery Market Growth Rate Analysis
• 5.4. Global Small Molecule Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Molecule Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Molecule Drug Discovery Total Addressable Market (TAM)

6. Small Molecule Drug Discovery Market Segmentation

• 6.1. Global Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule Drugs
• Biologic Drugs
• 6.2. Global Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Throughput Screening
• Pharmacogenomics
• Combinatorial Chemistry
• Nanotechnology
• Others
• 6.3. Global Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Central Nervous System
• Cardiovascular
• Respiratory
• Metabolic Disorders
• Gastrointestinal
• Others
• 6.4. Global Small Molecule Drug Discovery Market, Segmentation By Process/Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Target ID Or Validation
• Hit Generation And Selection
• Lead Identification
• Lead Optimization
• 6.5. Global Small Molecule Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Others
• 6.6. Global Small Molecule Drug Discovery Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generic Small Molecule Drugs
• Novel Small Molecule Drugs
• 6.7. Global Small Molecule Drug Discovery Market, Sub-Segmentation Of Biologic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Cell And Gene Therapies

7. Small Molecule Drug Discovery Market Regional And Country Analysis

• 7.1. Global Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Drug Discovery Market

• 8.1. Asia-Pacific Small Molecule Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Drug Discovery Market

• 9.1. China Small Molecule Drug Discovery Market Overview
• 9.2. China Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Drug Discovery Market

• 10.1. India Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Drug Discovery Market

• 11.1. Japan Small Molecule Drug Discovery Market Overview
• 11.2. Japan Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Drug Discovery Market

• 12.1. Australia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Drug Discovery Market

• 13.1. Indonesia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Drug Discovery Market

• 14.1. South Korea Small Molecule Drug Discovery Market Overview
• 14.2. South Korea Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Drug Discovery Market

• 15.1. Western Europe Small Molecule Drug Discovery Market Overview
• 15.2. Western Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Drug Discovery Market

• 16.1. UK Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Drug Discovery Market

• 17.1. Germany Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Drug Discovery Market

• 18.1. France Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Drug Discovery Market

• 19.1. Italy Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Drug Discovery Market

• 20.1. Spain Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Drug Discovery Market

• 21.1. Eastern Europe Small Molecule Drug Discovery Market Overview
• 21.2. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Drug Discovery Market

• 22.1. Russia Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Drug Discovery Market

• 23.1. North America Small Molecule Drug Discovery Market Overview
• 23.2. North America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Drug Discovery Market

• 24.1. USA Small Molecule Drug Discovery Market Overview
• 24.2. USA Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Drug Discovery Market

• 25.1. Canada Small Molecule Drug Discovery Market Overview
• 25.2. Canada Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Drug Discovery Market

• 26.1. South America Small Molecule Drug Discovery Market Overview
• 26.2. South America Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Drug Discovery Market

• 27.1. Brazil Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Drug Discovery Market

• 28.1. Middle East Small Molecule Drug Discovery Market Overview
• 28.2. Middle East Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Drug Discovery Market

• 29.1. Africa Small Molecule Drug Discovery Market Overview
• 29.2. Africa Small Molecule Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule Drug Discovery Market Competitive Landscape
• 30.2. Small Molecule Drug Discovery Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Drug Discovery Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson
• 31.2. Gilead Sciences Inc.
• 31.3. Merck KGaA
• 31.4. Novartis AG
• 31.5. 4SC AG
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Labcorp Drug Development
• 31.9. ICON Public Limited Company
• 31.10. Charles River Laboratories
• 31.11. Aluda Pharmaceuticals
• 31.12. Clinuvel Pharmaceuticals
• 31.13. Corcept Therapeutics
• 31.14. Edison Oncology
• 31.15. Escend Pharmaceuticals

32. Global Small Molecule Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Drug Discovery Market

34. Recent Developments In The Small Molecule Drug Discovery Market

35. Small Molecule Drug Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Small Molecule Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Molecule Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Molecule Drug Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer